These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

518 related items for PubMed ID: 21839219

  • 1. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Pallardo Mateu LM, Beltran Catalan S, Puig Alcaraz N, Sancho Calabuig A, Gavela Martinez E, Avila Bernabeu A, Crespo Albiach J.
    Transplant Proc; 2011; 43(6):2154-6. PubMed ID: 21839219
    [Abstract] [Full Text] [Related]

  • 2. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J, Sancho Calabuig A, Gavela Martinez E, Puig Alcaraz N, Beltran Catalan S, Avila Bernabeu A, Crespo Albiach J, Montoro JA, Pallardo Mateu LM.
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [Abstract] [Full Text] [Related]

  • 3. Clinical significance of post kidney transplant de novo DSA in otherwise stable grafts.
    Cooper JE, Gralla J, Chan L, Wiseman AC.
    Clin Transpl; 2011 Nov; ():359-64. PubMed ID: 22755431
    [Abstract] [Full Text] [Related]

  • 4. De novo donor specific antibodies and patient outcomes in renal transplantation.
    DeVos JM, Patel SJ, Burns KM, Dilioglou S, Gaber LW, Knight RJ, Gaber AO, Land GA.
    Clin Transpl; 2011 Nov; ():351-8. PubMed ID: 22755430
    [Abstract] [Full Text] [Related]

  • 5. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL, González-Escribano MF, González-Roncero FM, Acevedo-Calado MJ, Cabello-Chaves V, Gentil-Govantes MÁ, Núñez-Roldán A.
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [Abstract] [Full Text] [Related]

  • 6. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X, Ishida H, Yamaguchi Y, Tanabe K.
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [Abstract] [Full Text] [Related]

  • 7. A report of the epidemiology of de novo donor-specific anti-HLA antibodies (DSA) in "low-risk" renal transplant recipients.
    Rebellato LM, Everly MJ, Haisch CE, Ozawa M, Briley KP, Parker K, Catrou PG, Bolin P, Kendrick WT, Kendrick SA, Harland RC.
    Clin Transpl; 2011 Dec; ():337-40. PubMed ID: 22755428
    [Abstract] [Full Text] [Related]

  • 8. Successful transplantation across positive B-cell cross-match in deceased donor renal transplants.
    Goh A, Oei E, Vathsala A.
    Transplant Proc; 2012 Jan; 44(1):193-9. PubMed ID: 22310613
    [Abstract] [Full Text] [Related]

  • 9. Incidences of preformed and de novo donor-specific HLA antibodies and their clinicohistological correlates in the early course of kidney transplantation.
    Huang Y, Ramon D, Luan FL, Sung R, Samaniego M.
    Clin Transpl; 2012 Jan; ():247-56. PubMed ID: 23721029
    [Abstract] [Full Text] [Related]

  • 10. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N, Terasaki PI, Budde K, Liefeldt L, Kahl A, Reinke P, Pratschke J, Rudolph B, Schmidt D, Salama A, Schönemann C.
    Transplantation; 2009 May 27; 87(10):1505-13. PubMed ID: 19461487
    [Abstract] [Full Text] [Related]

  • 11. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 12. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation.
    Lee HS, Kim MS, Kim YS, Joo DJ, Ju MK, Kim SJ, Kim SI, Huh KH, Park K.
    Transplant Proc; 2012 Jan 20; 44(1):273-5. PubMed ID: 22310631
    [Abstract] [Full Text] [Related]

  • 13. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation.
    Thiyagarajan UM, Bagul A, Frost J, Horsburgh T, Nicholson ML.
    Transplant Proc; 2012 Jun 20; 44(5):1231-5. PubMed ID: 22663991
    [Abstract] [Full Text] [Related]

  • 14. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS, Iniotaki AG, Kontou EN, Darema MN, Apostolaki MD, Kostakis AG, Boletis JN.
    Transpl Int; 2011 Nov 20; 24(11):1084-93. PubMed ID: 21848902
    [Abstract] [Full Text] [Related]

  • 15. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
    Lawrence C, Willicombe M, Brookes PA, Santos-Nunez E, Bajaj R, Cook T, Roufosse C, Taube D, Warrens AN.
    Transplantation; 2013 Jan 27; 95(2):341-6. PubMed ID: 23197178
    [Abstract] [Full Text] [Related]

  • 16. Low levels of human leukocyte antigen donor-specific antibodies detected by solid phase assay before transplantation are frequently clinically irrelevant.
    Aubert V, Venetz JP, Pantaleo G, Pascual M.
    Hum Immunol; 2009 Aug 27; 70(8):580-3. PubMed ID: 19375474
    [Abstract] [Full Text] [Related]

  • 17. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
    Marfo K, Ajaimy M, Colovai A, Kayler L, Greenstein S, Lubetzky M, Gupta A, Kamal L, de Boccardo G, Masiakos P, Kinkhabwala M, Akalin E.
    Transplantation; 2014 Nov 27; 98(10):1082-8. PubMed ID: 24873780
    [Abstract] [Full Text] [Related]

  • 18. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC, Ozawa M.
    Clin Transpl; 2007 Nov 27; ():219-26. PubMed ID: 18642453
    [Abstract] [Full Text] [Related]

  • 19. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS, Vasilescu R, Tanriover B, Coppleson Y, Rekhtman Y, Hardy MA, Dube G, Crew RJ, Ratner LE, Cohen DJ, Mohan S.
    Transplantation; 2014 Mar 27; 97(6):642-7. PubMed ID: 24637863
    [Abstract] [Full Text] [Related]

  • 20. Early findings of prospective anti-HLA donor specific antibodies monitoring study in pancreas transplantation: Indiana University Health Experience.
    Mujtaba MA, Fridell JA, Higgins N, Sharfuddin AA, Yaqub MS, Kandula P, Chen J, Mishler DP, Lobashevsky A, Book B, Powelson J, Taber TE.
    Clin Transplant; 2012 Mar 27; 26(5):E492-9. PubMed ID: 22938159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.